KP
MDT icon

Kiltearn Partners’s Medtronic MDT Stock Holding History

Kiltearn Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Sell
142,788
-6,773
-5% -$546K 2.71% 14
2026
Q1 		$13M Sell
149,561
-31,200
-17% -$2.99M 3.49% 14
2025
Q4 		$17.4M Sell
180,761
-35,800
-17% -$3.48M 3.76% 8
2025
Q3 		$20.6M Sell
216,561
-16,200
-7% -$1.49M 4.13% 8
2025
Q2 		$20.3M Sell
232,761
-18,800
-7% -$1.59M 4.08% 9
2025
Q1 		$22.6M Sell
251,561
-44,700
-15% -$4M 4.31% 9
2024
Q4 		$23.7M Sell
296,261
-31,600
-10% -$2.74M 3.91% 8
2024
Q3 		$29.5M Sell
327,861
-31,900
-9% -$2.68M 4.01% 11
2024
Q2 		$28.3M Buy
359,761
+25,900
+8% +$2.12M 3.43% 11
2024
Q1 		$29.1M Sell
333,861
-62,200
-16% -$5.31M 2.69% 15
2023
Q4 		$32.6M Buy
396,061
+154,961
+64% +$11.8M 2.51% 17
2023
Q3 		$18.9M Sell
241,100
-8,400
-3% -$703K 1.49% 28
2023
Q2 		$22M Sell
249,500
-7,500
-3% -$646K 1.61% 26
2023
Q1 		$20.7M Buy
257,000
+61,500
+31% +$5.01M 1.5% 27
2022
Q4 		$15.2M Buy
+195,500
New +$15.8M 1.12% 30

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Kiltearn Partners's MDT Position: Q2 2026 in Review

Kiltearn Partners reduced its Medtronic (MDT) stake by 4.5% in Q2 2026, selling an estimated $546K and leaving 142,788 shares worth $11.2M. The position accounts for 2.71% of the portfolio, ranked #14.

Kiltearn Partners first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $32.6M in Q4 2023. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Kiltearn Partners held 142,788 shares of Medtronic worth $11.2M as of Q2 2026.
  • Kiltearn Partners sold 6,773 Medtronic shares in Q2 2026, an estimated $546K.
  • Medtronic made up 2.71% of Kiltearn Partners's portfolio in Q2 2026, its #14 holding.
  • Kiltearn Partners first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Kiltearn Partners's Medtronic position peaked at $32.6M in Q4 2023.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kiltearn Partners's 13F filing for Q2 2026, filed 12 Aug 2026.